INCOME STATEMENT
Alembic Pharmaceuticals Ltd.
BSE
Jun 02, 04:01
994.95
-22.25 ( -2.19%)
Volume
7347
Prev. Close
1017.20
Open Price
1017.40
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 02, 03:49
996.00
-22.05 ( -2.17%)
Volume
70556
Prev. Close
1018.05
Open Price
1010.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
996.00 (84)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE901L01018
|
Market Cap. ( ₹ in Cr. )
|
19577.69
|
P/BV
|
4.01
|
Book Value ( ₹ )
|
248.68
|
BSE Code
|
533573
|
52 Week High/Low ( ₹ )
|
1304/725
|
FV/ML
|
2/1
|
P/E(X)
|
33.56
|
NSE Code
|
APLLTDEQ
|
Book Closure
|
15/07/2024
|
EPS ( ₹ )
|
29.68
|
Div Yield (%)
|
1.10
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 6032.63 | 5757.55 | 5003.13 | 4987.49 | 4934.86 |
Other Operating Revenues | 0.00 | 116.51 | 145.87 | 47.92 | 116.58 |
Total Operating Revenues | 6032.63 | 5874.06 | 5149.00 | 5035.41 | 5051.44 |
| | | | | |
Other Income | 47.88 | 31.32 | 3.54 | 51.14 | 9.73 |
Total Revenue | 6080.51 | 5905.38 | 5152.54 | 5086.55 | 5061.17 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 1672.17 | 1403.01 | 1250.08 | 1129.11 | 1175.71 |
Purchase Of Stock-In Trade | 385.14 | 449.70 | 337.21 | 353.25 | 279.33 |
Operating And Direct Expenses | 0.00 | 0.00 | 31.02 | 0.00 | 0.00 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -268.54 | -52.36 | 72.84 | 19.87 | -157.13 |
Employee Benefit Expenses | 1466.57 | 1335.91 | 1094.82 | 1062.30 | 948.27 |
Finance Costs | 76.47 | 54.47 | 49.00 | 17.02 | 12.77 |
Depreciation And Amortisation Expenses | 277.08 | 271.14 | 272.95 | 284.92 | 152.60 |
Other Expenses | 1875.90 | 1739.28 | 1698.68 | 1562.08 | 1233.03 |
Total Expenses | 5484.79 | 5201.15 | 4806.60 | 4428.55 | 3644.58 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 595.72 | 704.23 | 345.94 | 658.00 | 1416.59 |
| | | | | |
Exceptional Items | 12.87 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit/Loss Before Tax | 608.59 | 704.23 | 345.94 | 658.00 | 1416.59 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 105.47 | 41.50 | 0.00 | 115.70 | 241.20 |
Tax For Earlier Years | 0.00 | -3.75 | -0.79 | -1.25 | 0.00 |
Total Tax Expenses | 105.47 | 37.75 | -0.79 | 114.45 | 241.20 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 503.12 | 666.48 | 346.73 | 543.55 | 1175.39 |
| | | | | |
Profit/Loss From Continuing Operations | 503.12 | 666.48 | 346.73 | 543.55 | 1175.39 |
| | | | | |
Profit/Loss For The Period | 503.12 | 666.48 | 346.73 | 543.55 | 1175.39 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 25.60 | 33.91 | 17.64 | 27.65 | 60.67 |
Diluted EPS (Rs.) | 25.60 | 33.91 | 17.64 | 27.65 | 60.67 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 157.25 | 196.56 | 275.19 | 0.00 |
Equity Dividend Rate (%) | 550.00 | 550.00 | 400.00 | 500.00 | 700.00 |